Literature DB >> 28304327

Retinopathy of prematurity in Indonesia: Incidence and risk factors.

J Edy Siswanto1, Pieter Jj Sauer2.   

Abstract

BACKGROUND: Retinopathy of prematurity (ROP) is a vaso-proliferative disease of the eye, which mainly affects preterm newborn infants with an incompletely vascularized retina. The incidence of ROP has increased in industrialized countries due to the increased survival of extremely low birth weight (ELBW) infants. ROP is also increasing in developing countries like Indonesia, where it is most likely due to the improved survival of ELBW infants.
OBJECTIVE: To ascertain the incidence of ROP and possible risk factors associated with the development of ROP in preterm infants in Indonesia.
METHODS: We reviewed the literature on the incidence and potential risk factors for the development of ROP in Indonesia, obtained data from three referral eye clinics and added data from our institution.
RESULTS: The reported incidence of all stages of ROP in infants with a gestational age of <32 weeks ranged from 18-30%. One study showed that ROP also occurred at older gestational ages. Blindness due to ROP was seen in infants up to 35 weeks and with a birth weight of 2000 g.
CONCLUSION: Retinopathy of prematurity is an important cause of ocular morbidity and blindness in Indonesia. The overall incidence of ROP in infants born below 32 weeks in Indonesia is higher than in developed countries, and it is seen in infants with older gestational ages. This might be due to a less strict monitoring during the use of oxygen in Indonesia compared to industrialized countries.

Entities:  

Keywords:  Indonesia; ROP; Risk factors; incidence

Mesh:

Year:  2017        PMID: 28304327     DOI: 10.3233/NPM-915142

Source DB:  PubMed          Journal:  J Neonatal Perinatal Med        ISSN: 1878-4429


  8 in total

1.  Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study.

Authors:  Yingying Chen; Shaoli Wang; Siying Chen; Xingyue Chen; Lizhen Han; Qionglei Zhong; Kaiyan Zhang
Journal:  BMC Ophthalmol       Date:  2022-06-21       Impact factor: 2.086

Review 2.  The role of anti-vascular endothelial growth factor in treatment of retinopathy of prematurity-a current review.

Authors:  Shing Chuen Chow; Pun Yuet Lam; Wai Ching Lam; Nicholas Siu Kay Fung
Journal:  Eye (Lond)       Date:  2022-01-11       Impact factor: 4.456

3.  Incidence and Risk Factors for Retinopathy of Prematurity in Tabuk City, KSA.

Authors:  Hani B AlBalawi; Nada S AlBalawi; Nada A AlSuhaimi; Amani A AlBalawi; Amani S AlAtawi; Hyder O Mirghani; Hassan A Al-Dhibi; Saad H AlEnezi
Journal:  Middle East Afr J Ophthalmol       Date:  2020-07-20

4.  Norrie disease gene polymorphism in Indonesian infants with retinopathy of prematurity.

Authors:  J Edy Siswanto; Sudarto Ronoatmodjo; Rita S Sitorus; Ag Soemantri; Iswari Setijaningsih; Pieter J J Sauer
Journal:  BMJ Open Ophthalmol       Date:  2019-02-27

5.  Anatomic outcomes of laser indirect ophthalmoscopy for retinopathy of prematurity in a tertiary referral center in the Philippines.

Authors:  David Francis Fullon Chan; Milagros M Herrera-Arroyo
Journal:  BMC Res Notes       Date:  2019-05-10

6.  Multicentre survey of retinopathy of prematurity in Indonesia.

Authors:  J Edy Siswanto; Arend F Bos; Peter H Dijk; Rinawati Rohsiswatmo; Gatot Irawan; Eko Sulistijono; Pertin Sianturi; Dewi A Wisnumurti; Rocky Wilar; Pieter J J Sauer
Journal:  BMJ Paediatr Open       Date:  2021-01-22

Review 7.  How to prevent ROP in preterm infants in Indonesia?

Authors:  Johanes Edy Siswanto; Peter H Dijk; Arend F Bos; Rita S Sitorus; Asri C Adisasmita; Sudarto Ronoatmodjo; Pieter J J Sauer
Journal:  Health Sci Rep       Date:  2021-01-18

Review 8.  Prevalence and risk factors of retinopathy of prematurity in Iran: a systematic review and meta-analysis.

Authors:  Milad Azami; Zahra Jaafari; Shoboo Rahmati; Afsar Dastjani Farahani; Gholamreza Badfar
Journal:  BMC Ophthalmol       Date:  2018-04-02       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.